Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation
10.1038/ni.1601
Crossref journal-article
Springer Science and Business Media LLC
Nature Immunology (297)
Bibliography

Burgdorf, S., Schölz, C., Kautz, A., Tampé, R., & Kurts, C. (2008). Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nature Immunology, 9(5), 558–566.

Authors 5
  1. Sven Burgdorf (first)
  2. Christian Schölz (additional)
  3. Andreas Kautz (additional)
  4. Robert Tampé (additional)
  5. Christian Kurts (additional)
References 50 Referenced 317
  1. den Haan, J.M., Lehar, S.M. & Bevan, M.J. CD8+ but not CD8− dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192, 1685–1696 (2000). (10.1084/jem.192.12.1685) / J. Exp. Med. by JM den Haan (2000)
  2. Kurts, C., Cannarile, M., Klebba, I. & Brocker, T. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J. Immunol. 166, 1439–1442 (2001). (10.4049/jimmunol.166.3.1439) / J. Immunol. by C Kurts (2001)
  3. Bevan, M.J. Cross-priming. Nat. Immunol. 7, 363–365 (2006). (10.1038/ni0406-363) / Nat. Immunol. by MJ Bevan (2006)
  4. Villadangos, J.A., Heath, W.R. & Carbone, F.R. Outside looking in: the inner workings of the cross-presentation pathway within dendritic cells. Trends Immunol. 28, 45–47 (2007). (10.1016/j.it.2006.12.008) / Trends Immunol. by JA Villadangos (2007)
  5. Kurts, C. et al. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184, 923–930 (1996). (10.1084/jem.184.3.923) / J. Exp. Med. by C Kurts (1996)
  6. Kurts, C., Miller, J.F., Subramaniam, R.M., Carbone, F.R. & Heath, W.R. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J. Exp. Med. 188, 409–414 (1998). (10.1084/jem.188.2.409) / J. Exp. Med. by C Kurts (1998)
  7. Li, M. et al. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J. Immunol. 166, 6099–6103 (2001). (10.4049/jimmunol.166.10.6099) / J. Immunol. by M Li (2001)
  8. Beutler, B., Hoebe, K., Du, X. & Ulevitch, R.J. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J. Leukoc. Biol. 74, 479–485 (2003). (10.1189/jlb.0203082) / J. Leukoc. Biol. by B Beutler (2003)
  9. Kopp, E. & Medzhitov, R. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15, 396–401 (2003). (10.1016/S0952-7915(03)00080-3) / Curr. Opin. Immunol. by E Kopp (2003)
  10. Hemmi, H. & Akira, S. TLR signalling and the function of dendritic cells. Chem. Immunol. Allergy 86, 120–135 (2005). (10.1159/000086657) / Chem. Immunol. Allergy by H Hemmi (2005)
  11. Maurer, T. et al. CpG-DNA aided cross-presentation of soluble antigens by dendritic cells. Eur. J. Immunol. 32, 2356–2364 (2002). (10.1002/1521-4141(200208)32:8<2356::AID-IMMU2356>3.0.CO;2-Z) / Eur. J. Immunol. by T Maurer (2002)
  12. Datta, S.K. et al. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J. Immunol. 170, 4102–4110 (2003). (10.4049/jimmunol.170.8.4102) / J. Immunol. by SK Datta (2003)
  13. Hoebe, K. et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat. Immunol. 4, 1223–1229 (2003). (10.1038/ni1010) / Nat. Immunol. by K Hoebe (2003)
  14. Gil-Torregrosa, B.C. et al. Control of cross-presentation during dendritic cell maturation. Eur. J. Immunol. 34, 398–407 (2004). (10.1002/eji.200324508) / Eur. J. Immunol. by BC Gil-Torregrosa (2004)
  15. Schulz, O. et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433, 887–892 (2005). (10.1038/nature03326) / Nature by O Schulz (2005)
  16. Weck, M.M. et al. TLR ligands differentially affect uptake and presentation of cellular antigens. Blood 109, 3890–3894 (2007). (10.1182/blood-2006-04-015719) / Blood by MM Weck (2007)
  17. Abele, R. & Tampé, R. The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing. Physiology (Bethesda) 19, 216–224 (2004). / Physiology (Bethesda) by R Abele (2004)
  18. Ackerman, A.L. & Cresswell, P. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5, 678–684 (2004). (10.1038/ni1082) / Nat. Immunol. by AL Ackerman (2004)
  19. Brossart, P. & Bevan, M.J. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 90, 1594–1599 (1997). (10.1182/blood.V90.4.1594) / Blood by P Brossart (1997)
  20. Norbury, C.C., Chambers, B.J., Prescott, A.R., Ljunggren, H.G. & Watts, C. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur. J. Immunol. 27, 280–288 (1997). (10.1002/eji.1830270141) / Eur. J. Immunol. by CC Norbury (1997)
  21. Ackerman, A.L., Kyritsis, C., Tampé, R. & Cresswell, P. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc. Natl. Acad. Sci. USA 100, 12889–12894 (2003). (10.1073/pnas.1735556100) / Proc. Natl. Acad. Sci. USA by AL Ackerman (2003)
  22. Norbury, C.C. et al. CD8+ T cell cross-priming via transfer of proteasome substrates. Science 304, 1318–1321 (2004). (10.1126/science.1096378) / Science by CC Norbury (2004)
  23. Ackerman, A.L., Kyritsis, C., Tampé, R. & Cresswell, P. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nat. Immunol. 6, 107–113 (2005). (10.1038/ni1147) / Nat. Immunol. by AL Ackerman (2005)
  24. Imai, J., Hasegawa, H., Maruya, M., Koyasu, S. & Yahara, I. Exogenous antigens are processed through the endoplasmic reticulum-associated degradation (ERAD) in cross-presentation by dendritic cells. Int. Immunol. 17, 45–53 (2005). (10.1093/intimm/dxh184) / Int. Immunol. by J Imai (2005)
  25. Ackerman, A.L., Giodini, A. & Cresswell, P. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 25, 607–617 (2006). (10.1016/j.immuni.2006.08.017) / Immunity by AL Ackerman (2006)
  26. Burgdorf, S., Kautz, A., Bohnert, V., Knolle, P.A. & Kurts, C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 316, 612–616 (2007). (10.1126/science.1137971) / Science by S Burgdorf (2007)
  27. Song, R. & Harding, C.V. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J. Immunol. 156, 4182–4190 (1996). (10.4049/jimmunol.156.11.4182) / J. Immunol. by R Song (1996)
  28. Houde, M. et al. Phagosomes are competent organelles for antigen cross-presentation. Nature 425, 402–406 (2003). (10.1038/nature01912) / Nature by M Houde (2003)
  29. Guermonprez, P. et al. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425, 397–402 (2003). (10.1038/nature01911) / Nature by P Guermonprez (2003)
  30. Touret, N. et al. Quantitative and dynamic assessment of the contribution of the ER to phagosome formation. Cell 123, 157–170 (2005). (10.1016/j.cell.2005.08.018) / Cell by N Touret (2005)
  31. Burgdorf, S., Lukacs-Kornek, V. & Kurts, C. The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J. Immunol. 176, 6770–6776 (2006). (10.4049/jimmunol.176.11.6770) / J. Immunol. by S Burgdorf (2006)
  32. Riese, R.J. & Chapman, H.A. Cathepsins and compartmentalization in antigen presentation. Curr. Opin. Immunol. 12, 107–113 (2000). (10.1016/S0952-7915(99)00058-8) / Curr. Opin. Immunol. by RJ Riese (2000)
  33. Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P. & Amigorena, S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell Biol. 1, 362–368 (1999). (10.1038/14058) / Nat. Cell Biol. by A Rodriguez (1999)
  34. Hotta, C., Fujimaki, H., Yoshinari, M., Nakazawa, M. & Minami, M. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells. Immunology 117, 97–107 (2006). (10.1111/j.1365-2567.2005.02270.x) / Immunology by C Hotta (2006)
  35. Song, R., Porgador, A. & Harding, C.V. Peptide-receptive class I major histocompatibility complex molecules on TAP-deficient and wild-type cells and their roles in the processing of exogenous antigens. Immunology 97, 316–324 (1999). (10.1046/j.1365-2567.1999.00759.x) / Immunology by R Song (1999)
  36. Kyritsis, C. et al. Molecular mechanism and structural aspects of transporter associated with antigen processing inhibition by the cytomegalovirus protein US6. J. Biol. Chem. 276, 48031–48039 (2001). (10.1074/jbc.M108528200) / J. Biol. Chem. by C Kyritsis (2001)
  37. Ciechanover, A., Schwartz, A.L. & Lodish, H.F. Sorting and recycling of cell surface receptors and endocytosed ligands: the asialoglycoprotein and transferrin receptors. J. Cell. Biochem. 23, 107–130 (1983). (10.1002/jcb.240230111) / J. Cell. Biochem. by A Ciechanover (1983)
  38. Reid, P.A. & Watts, C. Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments. Nature 346, 655–657 (1990). (10.1038/346655a0) / Nature by PA Reid (1990)
  39. van Weert, A.W., Geuze, H.J., Groothuis, B. & Stoorvogel, W. Primaquine interferes with membrane recycling from endosomes to the plasma membrane through a direct interaction with endosomes which does not involve neutralisation of endosomal pH nor osmotic swelling of endosomes. Eur. J. Cell Biol. 79, 394–399 (2000). (10.1078/0171-9335-00062) / Eur. J. Cell Biol. by AW van Weert (2000)
  40. Porgador, A., Yewdell, J.W., Deng, Y., Bennink, J.R. & Germain, R.N. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6, 715–726 (1997). (10.1016/S1074-7613(00)80447-1) / Immunity by A Porgador (1997)
  41. Bancherau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245–252 (1998). (10.1038/32588) / Nature by J Bancherau (1998)
  42. Cella, M., Engering, A., Pinet, V., Pieters, J. & Lanzavecchia, A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782–787 (1997). (10.1038/42030) / Nature by M Cella (1997)
  43. Turley, S.J. et al. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288, 522–527 (2000). (10.1126/science.288.5465.522) / Science by SJ Turley (2000)
  44. Trombetta, E.S., Ebersold, M., Garrett, W., Pypaert, M. & Mellman, I. Activation of lysosomal function during dendritic cell maturation. Science 299, 1400–1403 (2003). (10.1126/science.1080106) / Science by ES Trombetta (2003)
  45. Blander, J.M. & Medzhitov, R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440, 808–812 (2006). (10.1038/nature04596) / Nature by JM Blander (2006)
  46. Watanabe, J., Miyazaki, Y., Zimmerman, G.A., Albertine, K.H. & McIntyre, T.M. Endotoxin contamination of ovalbumin suppresses murine immunologic responses and development of airway hyper-reactivity. J. Biol. Chem. 278, 42361–42368 (2003). (10.1074/jbc.M307752200) / J. Biol. Chem. by J Watanabe (2003)
  47. Gagnon, E. et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110, 119–131 (2002). (10.1016/S0092-8674(02)00797-3) / Cell by E Gagnon (2002)
  48. Blander, J.M. & Medzhitov, R. Regulation of phagosome maturation by signals from toll-like receptors. Science 304, 1014–1018 (2004). (10.1126/science.1096158) / Science by JM Blander (2004)
  49. Van Meirvenne, S. et al. Efficient genetic modification of murine dendritic cells by electroporation with mRNA. Cancer Gene Ther. 9, 787–797 (2002). (10.1038/sj.cgt.7700499) / Cancer Gene Ther. by S Van Meirvenne (2002)
  50. Burgdorf, S., Leister, P. & Scheidtmann, K.H. TSG101 interacts with apoptosis-antagonizing transcription factor and enhances androgen receptor-mediated transcription by promoting its monoubiquitination. J. Biol. Chem. 279, 17524–17534 (2004). (10.1074/jbc.M313703200) / J. Biol. Chem. by S Burgdorf (2004)
Dates
Type When
Created 17 years, 5 months ago (March 30, 2008, 3:32 p.m.)
Deposited 2 years, 3 months ago (May 17, 2023, 6:21 a.m.)
Indexed 1 month, 2 weeks ago (July 16, 2025, 8:09 a.m.)
Issued 17 years, 5 months ago (March 30, 2008)
Published 17 years, 5 months ago (March 30, 2008)
Published Online 17 years, 5 months ago (March 30, 2008)
Published Print 17 years, 3 months ago (May 1, 2008)
Funders 0

None

@article{Burgdorf_2008, title={Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation}, volume={9}, ISSN={1529-2916}, url={http://dx.doi.org/10.1038/ni.1601}, DOI={10.1038/ni.1601}, number={5}, journal={Nature Immunology}, publisher={Springer Science and Business Media LLC}, author={Burgdorf, Sven and Schölz, Christian and Kautz, Andreas and Tampé, Robert and Kurts, Christian}, year={2008}, month=mar, pages={558–566} }